Novan Therapeutics' Series B Round

Novan Therapeutics raised a round of funding on September 12, 2011.

Novan is a clinical-stage drug development company aiming to commercialize nitric oxide-based products in selected therapeutic areas. The Company's core technologies solve the delivery issues with nit…

Articles about Novan Therapeutics' Series B Round: